Basel Altrabulsi

705 total citations
16 papers, 494 citations indexed

About

Basel Altrabulsi is a scholar working on Infectious Diseases, Surgery and Epidemiology. According to data from OpenAlex, Basel Altrabulsi has authored 16 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 3 papers in Surgery and 3 papers in Epidemiology. Recurrent topics in Basel Altrabulsi's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 epidemiological studies (3 papers) and COVID-19 Clinical Research Studies (3 papers). Basel Altrabulsi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 epidemiological studies (3 papers) and COVID-19 Clinical Research Studies (3 papers). Basel Altrabulsi collaborates with scholars based in United States, United Arab Emirates and Egypt. Basel Altrabulsi's co-authors include Anaís Malpica, Diane C. Bodurka, Michael T. Deavers, Russell Broaddus, Elvio G. Silva, George J. Netto, Marlon F. Levy, Robert M. Goldstein, Göran B. Klintmalm and Lisa Fichtel and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Epidemiology and The American Journal of Surgical Pathology.

In The Last Decade

Basel Altrabulsi

16 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Basel Altrabulsi United States 9 99 98 94 85 79 16 494
Marienn Réti Hungary 16 330 3.3× 89 0.9× 56 0.6× 109 1.3× 27 0.3× 57 885
Andres Chiesa‐Vottero United States 9 26 0.3× 140 1.4× 182 1.9× 20 0.2× 73 0.9× 23 526
Shlomit Orgad Israel 12 150 1.5× 41 0.4× 54 0.6× 23 0.3× 22 0.3× 26 623
Arnold van der Meer Netherlands 13 164 1.7× 47 0.5× 45 0.5× 7 0.1× 60 0.8× 22 780
Kerstin Pfeiffer Germany 11 68 0.7× 45 0.5× 42 0.4× 8 0.1× 129 1.6× 21 905
Nina K. Steckel Germany 18 513 5.2× 263 2.7× 33 0.4× 68 0.8× 18 0.2× 36 970
Neubury M. Lardy Netherlands 18 165 1.7× 68 0.7× 67 0.7× 68 0.8× 13 0.2× 47 911
L Markling Sweden 13 310 3.1× 64 0.7× 79 0.8× 79 0.9× 18 0.2× 28 616
Fuyuki Eguchi Japan 14 27 0.3× 87 0.9× 83 0.9× 64 0.8× 157 2.0× 36 628
L Pazmany United Kingdom 8 99 1.0× 50 0.5× 30 0.3× 12 0.1× 19 0.2× 11 617

Countries citing papers authored by Basel Altrabulsi

Since Specialization
Citations

This map shows the geographic impact of Basel Altrabulsi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Basel Altrabulsi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Basel Altrabulsi more than expected).

Fields of papers citing papers by Basel Altrabulsi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Basel Altrabulsi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Basel Altrabulsi. The network helps show where Basel Altrabulsi may publish in the future.

Co-authorship network of co-authors of Basel Altrabulsi

This figure shows the co-authorship network connecting the top 25 collaborators of Basel Altrabulsi. A scholar is included among the top collaborators of Basel Altrabulsi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Basel Altrabulsi. Basel Altrabulsi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Pederson, Holly J., Basel Altrabulsi, Stephanie Ricci, et al.. (2024). Germline Genetic Susceptibility Testing Among Emirati Nationals at Risk for Hereditary Breast and Ovarian Cancer Syndrome. JCO Global Oncology. 10(10). e2400352–e2400352. 1 indexed citations
2.
Hosani, Farida Al, Laila AbdelWareth, Rami H. Al‐Rifai, et al.. (2023). Susceptibility to reinfection with SARS-CoV-2 virus relative to existing antibody concentrations and T cell response. International Journal of Infectious Diseases. 131. 100–110. 6 indexed citations
3.
Al‐Rifai, Rami H., James G. Donnelly, Andrea Leinberger‐Jabari, et al.. (2023). Evaluation of post-vaccination immunoglobulin G antibodies and T-cell immune response after inoculation with different types and doses of SARS-CoV-2 vaccines: A retrospective cohort study. Frontiers in Medicine. 9. 1092646–1092646. 6 indexed citations
4.
Alsuwaidi, Ahmed R., Farida Ismail Al Hosani, Hassib Narchı, et al.. (2021). Seroprevalence of COVID-19 infection in the Emirate of Abu Dhabi, United Arab Emirates: a population-based cross-sectional study. International Journal of Epidemiology. 50(4). 1077–1090. 16 indexed citations
5.
Kesav, Praveen, Syed Hussain, Rajaie Namas, et al.. (2021). Primary Sjögren’s Syndrome Presenting as Recurrent Ischemic Strokes. The Neurohospitalist. 12(2). 341–345. 3 indexed citations
6.
Altrabulsi, Basel, et al.. (2021). Thyroid nodules in the gulf: Renewed interest and ongoing debate. 4(1). 4–5. 1 indexed citations
7.
Senok, Abiola, Hanan Al Suwaidi, Saba Al Heialy, et al.. (2020). <p>Saliva as an Alternative Specimen for Molecular COVID-19 Testing in Community Settings and Population-Based Screening</p>. Infection and Drug Resistance. Volume 13. 3393–3399. 50 indexed citations
8.
Senok, Abiola, Hanan Al Suwaidi, Areum Han, et al.. (2020). Saliva as an Alternative Specimen for Molecular COVID-19 Testing in Community Settings and Population-Based Screening.. SHILAP Revista de lepidopterología. 2 indexed citations
9.
Price, Vera H., Maria Hordinsky, Elise A. Olsen, et al.. (2008). Subcutaneous efalizumab is not effective in the treatment of alopecia areata. Journal of the American Academy of Dermatology. 58(3). 395–402. 53 indexed citations
10.
Netto, George J., Basel Altrabulsi, Nora Katabi, et al.. (2006). Radio‐frequency ablation of hepatocellular carcinoma before liver transplantation: a histologic and ‘TUNEL’ study. Liver International. 26(6). 746–751. 14 indexed citations
11.
Altrabulsi, Basel, et al.. (2006). Spindle basaloid squamous carcinoma of the upper aerodigestive tract: immunohistochemical and clinicopathological study of three cases. Annals of Diagnostic Pathology. 10(3). 149–153. 13 indexed citations
12.
Martín, Adrián, Robert M. Goldstein, Jane Dempster, et al.. (2006). Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation – a clinical and histological examination. Clinical Transplantation. 20(6). 695–705. 34 indexed citations
13.
Altrabulsi, Basel, Anaís Malpica, Michael T. Deavers, et al.. (2005). Undifferentiated Carcinoma of the Endometrium. The American Journal of Surgical Pathology. 29(10). 1316–1321. 132 indexed citations
14.
Altrabulsi, Basel, et al.. (2004). Endoscopic electrosurgical snare resection of leiomyosarcoma of main duodenal papilla. Gastrointestinal Endoscopy. 59(6). 743–745. 5 indexed citations
15.
Kuhn, Joseph A., Ronald C. Jones, Michael D. Grant, et al.. (2003). Predictors for Nonsentinel Node Involvement in Breast Cancer Patients with Micrometastases in the Sentinel Lymph Node. Baylor University Medical Center Proceedings. 16(1). 3–6. 16 indexed citations
16.
Smith, Douglas M., Edward Agura, George J. Netto, et al.. (2003). Liver transplant-associated graft-versus-host disease. Transplantation. 75(1). 118–126. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026